Found: 3
Select item for more details and to access through your institution.
Heterocyclic and non‐heterocyclic arena of monocarboxylate transporter inhibitors to battle tumorigenesis.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 102, n. 6, p. 1604, doi. 10.1111/cbdd.14342
- By:
- Publication type:
- Article
Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation.
- Published in:
- Clinical & Experimental Metastasis, 2024, v. 41, n. 1, p. 9, doi. 10.1007/s10585-023-10258-y
- By:
- Publication type:
- Article
A NEW PROMISE FROM NATURE; AN UPDATED REVIEW ON RESVERATROL - A MIRACLE DRUG.
- Published in:
- International Journal of Pharmacy & Life Sciences, 2019, v. 10, n. 6, p. 23
- By:
- Publication type:
- Article